SEC Form D private-offering filing

Aegle Therapeutics Corp

Name: Aegle Therapeutics Corp - new SEC Form D private-offering filing, Woburn, MA
Published: 2026-03-03

A new SEC Form D private-offering notice from Woburn, MA, a $700,000 filer-stated offering target in Biotech. The source filing is one click away.

Aegle Therapeutics Corp site↗ Verified via SEC Form D

Clinical stage biotechnology company developing extracellular vesicle therapies for rare dermatological diseases such as dystrophic epidermolysis bullosa and for burn care.

Filed 2026-03-03Filed to raise $700,000First money in 2025-12-30Raised so far $455,695HQ (as filed) Woburn, MASector Biotech ✓Stage (inferred) Pre-seedCall status Debt-only offering

Source linked the Form D on EDGAR↗Website verified aegletherapeutics.com↗Named in the filing 7 executives & directors

Open this row on the live feed →More new filings in Massachusetts →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.